Vortrag am FONDS professionell KONGRESSFranklin Genomic Advancements Fund - N (acc) EUR
| MVD-Fonds Rating | EDA |
|---|---|
  | - |
ISIN: LU2387457729 | WKN: A3C4V6
KAG: Franklin Templeton
NAV: 6,34 EUR am 07.11.2025
Portfolio
Watchlist
KursalarmChart
Kennzahlen Franklin Genomic Advancements Fund - N (acc) EUR
| 1M | 6M | 1J | 3J | 5J | 10J | Beginn | |
| Performance | +6,55% | +28,08% | +0,96% | -6,35% | - | - | -36,60% |
| Volatilität | +21,42% | +19,09% | +24,67% | +19,94% | - | - | +22,29% |
| Sharpe Ratio | +5,10 | +3,22 | -0,04 | -0,21 | - | - | -0,57 |
| Bester Monat | - | +15,60% | +15,60% | +15,60% | +15,60% | - | +15,60% |
| Schl. Monat | - | -5,42% | -11,80% | -11,80% | -18,20% | - | -18,20% |
| Max. Verlust | -2,76% | -5,25% | -26,89% | -33,66% | - | - | -55,71% |
Monatsperformance Franklin Genomic Advancements Fund - N (acc) EUR
| 2025 | 2024 | 2023 | 2022 | 2021 | |
| Januar | +5,79% | -0,33% | +3,62% | -18,20% | - |
| Februar | -4,69% | +7,72% | -3,95% | -3,75% | - |
| März | -11,80% | +1,83% | -0,47% | -0,78% | - |
| April | -3,90% | -7,34% | -3,50% | -7,59% | - |
| Mai | -5,42% | +1,45% | +1,81% | +0,42% | - |
| Juni | +3,27% | +3,18% | 0,00% | -1,55% | - |
| Juli | +3,17% | +4,78% | +2,59% | +12,75% | - |
| August | +4,80% | -3,24% | -0,32% | -8,01% | - |
| September | +3,30% | -3,65% | -5,70% | -5,39% | - |
| Oktober | +15,60% | -4,90% | -10,23% | +3,36% | - |
| November | -2,76% | +5,32% | +5,98% | -1,84% | -4,72% |
| Dezember | - | -4,57% | +7,76% | -8,63% | -3,07% |
| Gesamt | +4,80% | -0,99% | -3,78% | -35,08% | -7,65% |
Diese Fonds könnten Sie auch interessieren
Vergleichen Sie diese Fonds mit Ihrem ausgewähltem Fonds (Franklin Genomic Advancements Fund) oder suchen Sie weitere Top-Fonds zum Thema Aktien (Branche Gesundheit/Pharma) weltweit in EUR:
Fonds vergleichenWeitere ähnliche Fonds